SphK1, S1P, and S1PRs are gaining increasing importance as generic regulators of inflammatory immune responses, as discussed above, and the importance of the role of cellular SphK-S1P-S1PR action in colon cancers has been covered in a couple of recent reviews and book chapters [22,40]. The gene discussed is SPHK1; the disease is malignant colon neoplasm.